| Name | 2-Chloropyrimidine-5-sulfonylchloride |
|---|---|
| Synonyms |
2-chloropyrimidine-5-sulfonyl chloride
2-Chloro-5-pyrimidinesulfonyl chloride 5-Pyrimidinesulfonyl chloride, 2-chloro- |
| Density | 1.7±0.1 g/cm3 |
|---|---|
| Boiling Point | 383.2±15.0 °C at 760 mmHg |
| Molecular Formula | C4H2Cl2N2O2S |
| Molecular Weight | 213.042 |
| Flash Point | 185.6±20.4 °C |
| Exact Mass | 211.921402 |
| PSA | 68.30000 |
| LogP | 0.63 |
| Vapour Pressure | 0.0±0.8 mmHg at 25°C |
| Index of Refraction | 1.570 |
| HS Code | 2933599090 |
|---|
|
~97%
98026-88-1 |
| Literature: TAKEDA PHARMACEUTICAL COMPANY LIMITED Patent: WO2006/36024 A1, 2006 ; Location in patent: Page/Page column 159 ; |
|
~%
98026-88-1 |
| Literature: Bioorganic and Medicinal Chemistry Letters, , vol. 23, # 13 p. 3947 - 3953 |
| Precursor 2 | |
|---|---|
| DownStream 1 | |
| HS Code | 2933599090 |
|---|---|
| Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |